
    
      Patients will participate in two tDCS sessions (atDCS; sham) in a cross-over within subjects
      design. tDCS or placebo will be administered during simulatneous fMRI to assess neural
      signatures of the stimulation. Order of stimulation will be counterbalanced between subjects
    
  